Showing results (211-220 of 275) with videos related to
Sort By:
Pageof 28
Journal of Chemical Information and Modeling|November 22, 2021
Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 Mpro Protease through Virtual ScreeningJaime Rubio-Martínez, Ana Jiménez-Alesanco, Laura Ceballos-Laita, et al.Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.Scientific Reports|December 9, 2022
Filaggrin and cytokines in respiratory samples of preterm infants at risk for respiratory viral infectionJosé M Rodrigo-Muñoz, Beatriz Sastre, Laura Sánchez-García, et al.European Journal of Pediatrics|October 25, 2025
Impact of RSV hospitalization on healthcare costs, caregivers' productivity loss, and quality of life in children ≤ 2 years old in five European countriesJoanne G Wildenbeest, Louis Bont, Daniela Cianci, et al.Microorganisms|July 29, 2023
Adenovirus Infection in Hematopoietic and Solid Organ Paediatric Transplant Recipients: Treatment, Outcomes, and Use of CidofovirCarlos Grasa, Einés Monteagudo-Vilavedra, Elena Pérez-Arenas, et al.The Journal of Infection|May 1, 2022
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2Daniel Jiménez, Javier Martínez-Sanz, Talía Sainz, et al.European Journal of Pediatrics|August 30, 2021
Kawasaki disease in children younger than 6 months of age: characteristics of a Spanish cohortCarlos D Grasa, Elisa Fernández-Cooke, Judith Sánchez-Manubens, et al.The Pediatric Infectious Disease Journal|February 18, 2011
Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009Claudia Palladino, Francisco J Climent, M Isabel De José, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 22, 2025
Plasma calprotectin as a severity biomarker in pediatric invasive Streptococcus pyogenes infections: insights from a multicenter immune profiling study during an outbreakJosé Avendaño-Ortiz, David Aguilera-Alonso, Concepción M Rodríguez, et al.The Pediatric Infectious Disease Journal|May 7, 2024
Severe Impairment of T-cell Immunity and Pulmonary GvHD Are Major Risk Factors for Nontuberculous Mycobacterial Infection After Pediatric Allogeneic Hematopoietic Stem Cell TransplantationMarina Ascunce, Alejandra Coccolo, Yasmina Mozo, et al.Pageof 28